Safety, Pharmacokinetics, and Pharmacodynamics of a First-in-Class ClC-1 Inhibitor to Enhance Muscle Excitability: Phase I Randomized Controlled Trial.
Ruijs TQ, de Cuba CMKE, Heuberger JAAC, Hutchison J, Bold J, Grønnebæk TS, Jensen KG, Chin E, Quiroz JA, Petersen TK, Flagstad P, de Kam ML, van Esdonk MJ, Klaassen E, Doll RJ, Koopmans IW, de Goede AA, Aulin LBS, Pedersen TH, Groeneveld GJ.
Ruijs TQ, et al. Among authors: hutchison j.
Clin Pharmacol Ther. 2024 Dec 9. doi: 10.1002/cpt.3516. Online ahead of print.
Clin Pharmacol Ther. 2024.
PMID: 39651850